Skip to content
    Guidelines & Consensus

    circRNADisease v3.0 Integrates 15,390 Validated circRNA-Disease Associations

    Yang et alNucleic Acids Research

    The circRNADisease database has released version 3.0, providing an expanded, manually curated, and evidence-oriented repository of experimentally validated circular RNA (circRNA)–disease associations to assist in biomarker discovery and translational therapeutic research.
    The updated database contains 15 390 curated circRNA-disease entries encompassing 9168 circRNAs, 656 MONDO-standardized disease terms, and 66 species, reflecting more than double the data volume of version 2.0. To enhance reliability, each record is assigned an evidence-based confidence score based on the strength and breadth of supporting criteria, including clinical evidence, circular-transcript identity verification, expression detection, functional assays, molecular-mechanism validation, and bioinformatic analysis. Records also detail genomic coordinates, subcellular localization, experimental validation techniques, clinical significance, availability of raw data and code, and cross-references to standard disease terminologies.
    circRNADisease v3.0 introduces two new modules to link literature-curated associations with genomic and cellular context: Circ2CNV, which catalogs 2 962 504 circRNA-cancer cohort records with copy-number variations across 33 TCGA cohorts, and Circ2Celltype, which provides 2025 cell-type-resolved evidence records covering 29 distinct cell types. Alongside the previously established Circ2Mut module, these tools bridge circRNA dysregulation with somatic alterations and cell-type-specific pathology. The resource is openly accessible at http://cgga.org.cn/circRNADisease/.

    Key Takeaways

    • circRNADisease v3.0 expands to 15 390 curated circRNA-disease association entries across 9168 circRNAs, 656 MONDO-standardized disease terms, and 66 species, representing a more than twofold increase in data volume compared to v2.0.
    • The updated platform incorporates two new modules: Circ2CNV, comprising 2 962 504 circRNA-cancer cohort records with copy-number variations across 33 TCGA cancer cohorts, and Circ2Celltype, containing 2025 cell-type-resolved records across 29 cell types.
    • Each curated entry is assigned an evidence-based confidence score evaluating clinical evidence, circular-transcript identity verification, expression detection, functional experimentation, molecular-mechanism validation, and bioinformatic analysis.
    Read the original sourceNucleic Acids Research